Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
15 Oct 2021
Historique:
entrez: 8 10 2021
pubmed: 9 10 2021
medline: 21 10 2021
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused more than 160 million infections and more than 3 million deaths worldwide. Although effective vaccines are currently being deployed, the adaptive immune determinants that promote viral clearance and confer protection remain poorly defined. Using mouse models of SARS-CoV-2, we demonstrate that both humoral and cellular adaptive immunity contribute to viral clearance in the setting of primary infection. Furthermore, we find that either convalescent mice or mice that receive mRNA vaccination are protected from both homologous infection and infection with a variant of concern, B.1.351. In addition, we find that this protection is largely mediated by antibody response and not cellular immunity. These results highlight the in vivo protective capacity of antibodies generated to both vaccine and natural infection.

Identifiants

pubmed: 34623900
doi: 10.1126/sciimmunol.abl4509
pmc: PMC9047536
mid: NIHMS1795909
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabl4509

Subventions

Organisme : NIAID NIH HHS
ID : K08 AI163493
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States

Commentaires et corrections

Type : UpdateOf

Références

Lancet. 2021 Jun 19;397(10292):2331-2333
pubmed: 34090624
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
N Engl J Med. 2021 Apr 15;384(15):1412-1423
pubmed: 33626250
Cell. 2021 Jan 7;184(1):169-183.e17
pubmed: 33296701
Nature. 2020 Oct;586(7830):589-593
pubmed: 32785213
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
J Exp Med. 2021 Apr 5;218(4):
pubmed: 33464307
J Exp Med. 2020 Dec 7;217(12):
pubmed: 32750141
J Infect Dis. 2021 Jan 4;223(1):23-27
pubmed: 33089317
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2793-2795
pubmed: 32652231
Nat Immunol. 2020 Nov;21(11):1327-1335
pubmed: 32839612
Cell. 2021 Apr 29;184(9):2372-2383.e9
pubmed: 33743213
Nature. 2020 Oct;586(7830):578-582
pubmed: 32731258
N Engl J Med. 2020 Oct 15;383(16):1544-1555
pubmed: 32722908
Nature. 2020 Oct;586(7830):567-571
pubmed: 32756549
Nat Med. 2020 Jul;26(7):1033-1036
pubmed: 32398876
Cell Rep. 2021 Feb 9;34(6):108728
pubmed: 33516277
Immunity. 2016 Jun 21;44(6):1379-91
pubmed: 27287409
Cell. 2020 Dec 23;183(7):1901-1912.e9
pubmed: 33248470
Nat Med. 2021 Aug;27(8):1379-1384
pubmed: 34127854
N Engl J Med. 2021 Feb 11;384(6):533-540
pubmed: 33369366
J Immunol. 2021 Jul 15;207(2):376-379
pubmed: 34193597
Cell. 1992 Mar 6;68(5):869-77
pubmed: 1547488
Cell. 2021 Jan 7;184(1):76-91.e13
pubmed: 33147444
Nature. 2021 Feb;590(7847):630-634
pubmed: 33276369
N Engl J Med. 2021 May 13;384(19):1866-1868
pubmed: 33761203
NPJ Vaccines. 2021 Jan 25;6(1):16
pubmed: 33495468
Nature. 2021 Aug;596(7871):276-280
pubmed: 34237773
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
Cell Host Microbe. 2020 Jun 10;27(6):870-878
pubmed: 32464097
Science. 2020 Dec 4;370(6521):1227-1230
pubmed: 33115920
Nat Med. 2021 Jul;27(7):1205-1211
pubmed: 34002089
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
Nature. 2020 Oct;586(7830):583-588
pubmed: 32731257
Cell. 2020 Aug 6;182(3):734-743.e5
pubmed: 32643603
Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25057-25067
pubmed: 31767754
Nature. 1991 Apr 4;350(6317):423-6
pubmed: 1901381
Nature. 2020 Oct;586(7830):560-566
pubmed: 32854108
Nature. 2021 Jan;589(7843):603-607
pubmed: 33166988
J Infect. 2021 Mar;82(3):414-451
pubmed: 33121954
Science. 2020 Aug 14;369(6505):806-811
pubmed: 32434945
Nature. 2021 Apr;592(7853):283-289
pubmed: 33524990
Lancet. 2021 Apr 10;397(10282):1351-1362
pubmed: 33798499
Virology. 2005 Apr 25;335(1):34-45
pubmed: 15823604
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246

Auteurs

Benjamin Israelow (B)

Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.

Tianyang Mao (T)

Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.

Jonathan Klein (J)

Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.

Eric Song (E)

Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.

Bridget Menasche (B)

Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA.

Saad B Omer (SB)

Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Yale Institute for Global Health, Yale University, New Haven, CT, USA.

Akiko Iwasaki (A)

Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Howard Hughes Medical Institute, Chevy Chase, MD, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH